086900 — Medy Tox Balance Sheet
0.000.00%
Last trade - 00:00- KR₩679bn
- KR₩709bn
- KR₩247bn
Annual balance sheet for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 81,927 | 26,208 | 33,345 | 59,515 | 48,945 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 43,557 | 53,303 | 67,508 | 56,826 | 57,566 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 160,959 | 135,134 | 166,232 | 186,568 | 155,337 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 205,531 | 208,878 | 205,262 | 200,270 | 199,541 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 577,698 | 596,288 | 611,623 | 615,163 | 581,757 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 107,947 | 135,262 | 126,556 | 117,553 | 104,817 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 178,217 | 168,244 | 142,160 | 148,687 | 129,915 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 399,481 | 428,045 | 469,463 | 466,476 | 451,842 |
| Total Liabilities & Shareholders' Equity | 577,698 | 596,288 | 611,623 | 615,163 | 581,757 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |